eli lilly shares were higher and akouos soared after the pharmaceutical giant announced that it will buy the genetic medicine company focused on hearing improvement for up to 610 million the merger of these two companies is meant to help them accelerate gene therapies that will help improve hearing for patients according to a joint news release